1. Home
  2. FEAM vs ATOS Comparison

FEAM vs ATOS Comparison

Compare FEAM & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

N/A

Current Price

$3.49

Market Cap

89.1M

Sector

Industrials

ML Signal

N/A

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

N/A

Current Price

$0.73

Market Cap

100.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FEAM
ATOS
Founded
2016
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.1M
100.8M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
FEAM
ATOS
Price
$3.49
$0.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$8.13
$6.33
AVG Volume (30 Days)
79.2K
1.0M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$500.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.82
$0.55
52 Week High
$24.84
$1.29

Technical Indicators

Market Signals
Indicator
FEAM
ATOS
Relative Strength Index (RSI) 37.40 40.73
Support Level $3.68 $0.68
Resistance Level $4.21 $0.99
Average True Range (ATR) 0.27 0.05
MACD -0.01 -0.00
Stochastic Oscillator 12.80 10.91

Price Performance

Historical Comparison
FEAM
ATOS

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: